Interestingly, plasma neopterin levels, an indicator of IFN-γ activity, have been paralleled by increased levels of the TRP:KYN ratio, which is reflective of IDO activity in patients with metabolic disorders such as type 2 diabetes [118] and neurodegenerative disorders such as Huntington’s Disease [95]. Here, IDO1 is linked to type 2 diabetes mellitus.